Global Iodinated X-Ray Contrast Media Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to Iodinated X-Ray Contrast Media: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Iodinated X-Ray Contrast Media Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Ioversol
1.2.3 Iobitrol
1.2.4 Iohexol
1.2.5 Iodixanol
1.2.6 Others
1.3 Market Segmentation by Application
1.3.1 Global Iodinated X-Ray Contrast Media Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Iodinated X-Ray Contrast Media Revenue Estimates and Forecasts 2020-2031
2.2 Global Iodinated X-Ray Contrast Media Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Iodinated X-Ray Contrast Media Sales Estimates and Forecasts 2020-2031
2.4 Global Iodinated X-Ray Contrast Media Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Iodinated X-Ray Contrast Media Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Iodinated X-Ray Contrast Media Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Ioversol Market Size by Manufacturers
3.5.2 Iobitrol Market Size by Manufacturers
3.5.3 Iohexol Market Size by Manufacturers
3.5.4 Iodixanol Market Size by Manufacturers
3.5.5 Others Market Size by Manufacturers
3.6 Global Iodinated X-Ray Contrast Media Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Iodinated X-Ray Contrast Media Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Iodinated X-Ray Contrast Media Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Iodinated X-Ray Contrast Media Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Iodinated X-Ray Contrast Media Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Iodinated X-Ray Contrast Media Sales and Revenue by Type (2020-2031)
6.4 North America Iodinated X-Ray Contrast Media Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Iodinated X-Ray Contrast Media Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Iodinated X-Ray Contrast Media Sales and Revenue by Type (2020-2031)
7.4 Europe Iodinated X-Ray Contrast Media Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Iodinated X-Ray Contrast Media Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Iodinated X-Ray Contrast Media Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Iodinated X-Ray Contrast Media Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Iodinated X-Ray Contrast Media Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Iodinated X-Ray Contrast Media Sales and Revenue by Type (2020-2031)
9.4 Central and South America Iodinated X-Ray Contrast Media Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Iodinated X-Ray Contrast Media Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Iodinated X-Ray Contrast Media Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Iodinated X-Ray Contrast Media Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Iodinated X-Ray Contrast Media Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Business Overview
11.1.3 Bayer Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.1.4 Bayer Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Bayer Iodinated X-Ray Contrast Media Sales by Product in 2024
11.1.6 Bayer Iodinated X-Ray Contrast Media Sales by Application in 2024
11.1.7 Bayer Iodinated X-Ray Contrast Media Sales by Geographic Area in 2024
11.1.8 Bayer Iodinated X-Ray Contrast Media SWOT Analysis
11.1.9 Bayer Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Corporation Information
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.2.4 GE Healthcare Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 GE Healthcare Iodinated X-Ray Contrast Media Sales by Product in 2024
11.2.6 GE Healthcare Iodinated X-Ray Contrast Media Sales by Application in 2024
11.2.7 GE Healthcare Iodinated X-Ray Contrast Media Sales by Geographic Area in 2024
11.2.8 GE Healthcare Iodinated X-Ray Contrast Media SWOT Analysis
11.2.9 GE Healthcare Recent Developments
11.3 Fuji Pharma
11.3.1 Fuji Pharma Corporation Information
11.3.2 Fuji Pharma Business Overview
11.3.3 Fuji Pharma Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.3.4 Fuji Pharma Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Fuji Pharma Iodinated X-Ray Contrast Media Sales by Product in 2024
11.3.6 Fuji Pharma Iodinated X-Ray Contrast Media Sales by Application in 2024
11.3.7 Fuji Pharma Iodinated X-Ray Contrast Media Sales by Geographic Area in 2024
11.3.8 Fuji Pharma Iodinated X-Ray Contrast Media SWOT Analysis
11.3.9 Fuji Pharma Recent Developments
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Corporation Information
11.4.2 Daiichi Sankyo Business Overview
11.4.3 Daiichi Sankyo Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.4.4 Daiichi Sankyo Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Daiichi Sankyo Iodinated X-Ray Contrast Media Sales by Product in 2024
11.4.6 Daiichi Sankyo Iodinated X-Ray Contrast Media Sales by Application in 2024
11.4.7 Daiichi Sankyo Iodinated X-Ray Contrast Media Sales by Geographic Area in 2024
11.4.8 Daiichi Sankyo Iodinated X-Ray Contrast Media SWOT Analysis
11.4.9 Daiichi Sankyo Recent Developments
11.5 Bracco
11.5.1 Bracco Corporation Information
11.5.2 Bracco Business Overview
11.5.3 Bracco Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.5.4 Bracco Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Bracco Iodinated X-Ray Contrast Media Sales by Product in 2024
11.5.6 Bracco Iodinated X-Ray Contrast Media Sales by Application in 2024
11.5.7 Bracco Iodinated X-Ray Contrast Media Sales by Geographic Area in 2024
11.5.8 Bracco Iodinated X-Ray Contrast Media SWOT Analysis
11.5.9 Bracco Recent Developments
11.6 Guerbet
11.6.1 Guerbet Corporation Information
11.6.2 Guerbet Business Overview
11.6.3 Guerbet Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.6.4 Guerbet Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Guerbet Recent Developments
11.7 Imax
11.7.1 Imax Corporation Information
11.7.2 Imax Business Overview
11.7.3 Imax Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.7.4 Imax Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Imax Recent Developments
11.8 Grupo Juste
11.8.1 Grupo Juste Corporation Information
11.8.2 Grupo Juste Business Overview
11.8.3 Grupo Juste Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.8.4 Grupo Juste Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Grupo Juste Recent Developments
11.9 Takeda
11.9.1 Takeda Corporation Information
11.9.2 Takeda Business Overview
11.9.3 Takeda Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.9.4 Takeda Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Takeda Recent Developments
11.10 Hengrui Pharmaceuticals
11.10.1 Hengrui Pharmaceuticals Corporation Information
11.10.2 Hengrui Pharmaceuticals Business Overview
11.10.3 Hengrui Pharmaceuticals Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.10.4 Hengrui Pharmaceuticals Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Hengrui Pharmaceuticals Recent Developments
11.11 Brilliant Pharmaceutical
11.11.1 Brilliant Pharmaceutical Corporation Information
11.11.2 Brilliant Pharmaceutical Business Overview
11.11.3 Brilliant Pharmaceutical Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.11.4 Brilliant Pharmaceutical Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Brilliant Pharmaceutical Recent Developments
11.12 Shenghuaxi Pharmaceutical
11.12.1 Shenghuaxi Pharmaceutical Corporation Information
11.12.2 Shenghuaxi Pharmaceutical Business Overview
11.12.3 Shenghuaxi Pharmaceutical Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.12.4 Shenghuaxi Pharmaceutical Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Shenghuaxi Pharmaceutical Recent Developments
11.13 Neptunus Bio-pharmaceutical
11.13.1 Neptunus Bio-pharmaceutical Corporation Information
11.13.2 Neptunus Bio-pharmaceutical Business Overview
11.13.3 Neptunus Bio-pharmaceutical Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.13.4 Neptunus Bio-pharmaceutical Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Neptunus Bio-pharmaceutical Recent Developments
11.14 YRPG
11.14.1 YRPG Corporation Information
11.14.2 YRPG Business Overview
11.14.3 YRPG Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.14.4 YRPG Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 YRPG Recent Developments
11.15 CTTQ
11.15.1 CTTQ Corporation Information
11.15.2 CTTQ Business Overview
11.15.3 CTTQ Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.15.4 CTTQ Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 CTTQ Recent Developments
11.16 Consun Pharmaceutical
11.16.1 Consun Pharmaceutical Corporation Information
11.16.2 Consun Pharmaceutical Business Overview
11.16.3 Consun Pharmaceutical Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.16.4 Consun Pharmaceutical Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Consun Pharmaceutical Recent Developments
11.17 Liebel-Flarsheim Company LLC
11.17.1 Liebel-Flarsheim Company LLC Corporation Information
11.17.2 Liebel-Flarsheim Company LLC Business Overview
11.17.3 Liebel-Flarsheim Company LLC Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.17.4 Liebel-Flarsheim Company LLC Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Liebel-Flarsheim Company LLC Recent Developments
11.18 BeiLu Pharma
11.18.1 BeiLu Pharma Corporation Information
11.18.2 BeiLu Pharma Business Overview
11.18.3 BeiLu Pharma Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.18.4 BeiLu Pharma Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 BeiLu Pharma Recent Developments
11.19 Cadiasun Pharma GmbH
11.19.1 Cadiasun Pharma GmbH Corporation Information
11.19.2 Cadiasun Pharma GmbH Business Overview
11.19.3 Cadiasun Pharma GmbH Iodinated X-Ray Contrast Media Product Models, Descriptions and Specifications
11.19.4 Cadiasun Pharma GmbH Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Cadiasun Pharma GmbH Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Iodinated X-Ray Contrast Media Industry Chain
12.2 Iodinated X-Ray Contrast Media Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Iodinated X-Ray Contrast Media Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Iodinated X-Ray Contrast Media Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Iodinated X-Ray Contrast Media Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Iodinated X-Ray Contrast Media Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global Iodinated X-Ray Contrast Media Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Iodinated X-Ray Contrast Media Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Iodinated X-Ray Contrast Media Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Iodinated X-Ray Contrast Media Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Iodinated X-Ray Contrast Media Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Iodinated X-Ray Contrast Media Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Iodinated X-Ray Contrast Media Sales by Region (2020-2025) & (Units)
Table 8. Global Iodinated X-Ray Contrast Media Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Iodinated X-Ray Contrast Media Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global Iodinated X-Ray Contrast Media Sales Share by Manufacturers (2020-2025)
Table 12. Global Iodinated X-Ray Contrast Media Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Iodinated X-Ray Contrast Media Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Iodinated X-Ray Contrast Media by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iodinated X-Ray Contrast Media as of 2024)
Table 16. Global Iodinated X-Ray Contrast Media Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Iodinated X-Ray Contrast Media Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Iodinated X-Ray Contrast Media Manufacturing Base and Headquarters
Table 19. Global Iodinated X-Ray Contrast Media Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Iodinated X-Ray Contrast Media Sales by Type (2020-2025) & (Units)
Table 23. Global Iodinated X-Ray Contrast Media Sales by Type (2026-2031) & (Units)
Table 24. Global Iodinated X-Ray Contrast Media Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Iodinated X-Ray Contrast Media Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Iodinated X-Ray Contrast Media ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Iodinated X-Ray Contrast Media Sales by Application (2020-2025) & (Units)
Table 29. Global Iodinated X-Ray Contrast Media Sales by Application (2026-2031) & (Units)
Table 30. Iodinated X-Ray Contrast Media High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Iodinated X-Ray Contrast Media Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Iodinated X-Ray Contrast Media Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Iodinated X-Ray Contrast Media ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Iodinated X-Ray Contrast Media Growth Accelerators and Market Barriers
Table 37. North America Iodinated X-Ray Contrast Media Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Iodinated X-Ray Contrast Media Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Iodinated X-Ray Contrast Media Growth Accelerators and Market Barriers
Table 40. Europe Iodinated X-Ray Contrast Media Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Iodinated X-Ray Contrast Media Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Iodinated X-Ray Contrast Media Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Iodinated X-Ray Contrast Media Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Iodinated X-Ray Contrast Media Growth Accelerators and Market Barriers
Table 45. Southeast Asia Iodinated X-Ray Contrast Media Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Iodinated X-Ray Contrast Media Investment Opportunities and Key Challenges
Table 47. Central and South America Iodinated X-Ray Contrast Media Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Iodinated X-Ray Contrast Media Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Iodinated X-Ray Contrast Media Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Bayer Corporation Information
Table 51. Bayer Description and Major Businesses
Table 52. Bayer Product Models, Descriptions and Specifications
Table 53. Bayer Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Bayer Sales Value Proportion by Product in 2024
Table 55. Bayer Sales Value Proportion by Application in 2024
Table 56. Bayer Sales Value Proportion by Geographic Area in 2024
Table 57. Bayer Iodinated X-Ray Contrast Media SWOT Analysis
Table 58. Bayer Recent Developments
Table 59. GE Healthcare Corporation Information
Table 60. GE Healthcare Description and Major Businesses
Table 61. GE Healthcare Product Models, Descriptions and Specifications
Table 62. GE Healthcare Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. GE Healthcare Sales Value Proportion by Product in 2024
Table 64. GE Healthcare Sales Value Proportion by Application in 2024
Table 65. GE Healthcare Sales Value Proportion by Geographic Area in 2024
Table 66. GE Healthcare Iodinated X-Ray Contrast Media SWOT Analysis
Table 67. GE Healthcare Recent Developments
Table 68. Fuji Pharma Corporation Information
Table 69. Fuji Pharma Description and Major Businesses
Table 70. Fuji Pharma Product Models, Descriptions and Specifications
Table 71. Fuji Pharma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Fuji Pharma Sales Value Proportion by Product in 2024
Table 73. Fuji Pharma Sales Value Proportion by Application in 2024
Table 74. Fuji Pharma Sales Value Proportion by Geographic Area in 2024
Table 75. Fuji Pharma Iodinated X-Ray Contrast Media SWOT Analysis
Table 76. Fuji Pharma Recent Developments
Table 77. Daiichi Sankyo Corporation Information
Table 78. Daiichi Sankyo Description and Major Businesses
Table 79. Daiichi Sankyo Product Models, Descriptions and Specifications
Table 80. Daiichi Sankyo Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Daiichi Sankyo Sales Value Proportion by Product in 2024
Table 82. Daiichi Sankyo Sales Value Proportion by Application in 2024
Table 83. Daiichi Sankyo Sales Value Proportion by Geographic Area in 2024
Table 84. Daiichi Sankyo Iodinated X-Ray Contrast Media SWOT Analysis
Table 85. Daiichi Sankyo Recent Developments
Table 86. Bracco Corporation Information
Table 87. Bracco Description and Major Businesses
Table 88. Bracco Product Models, Descriptions and Specifications
Table 89. Bracco Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Bracco Sales Value Proportion by Product in 2024
Table 91. Bracco Sales Value Proportion by Application in 2024
Table 92. Bracco Sales Value Proportion by Geographic Area in 2024
Table 93. Bracco Iodinated X-Ray Contrast Media SWOT Analysis
Table 94. Bracco Recent Developments
Table 95. Guerbet Corporation Information
Table 96. Guerbet Description and Major Businesses
Table 97. Guerbet Product Models, Descriptions and Specifications
Table 98. Guerbet Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Guerbet Recent Developments
Table 100. Imax Corporation Information
Table 101. Imax Description and Major Businesses
Table 102. Imax Product Models, Descriptions and Specifications
Table 103. Imax Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Imax Recent Developments
Table 105. Grupo Juste Corporation Information
Table 106. Grupo Juste Description and Major Businesses
Table 107. Grupo Juste Product Models, Descriptions and Specifications
Table 108. Grupo Juste Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Grupo Juste Recent Developments
Table 110. Takeda Corporation Information
Table 111. Takeda Description and Major Businesses
Table 112. Takeda Product Models, Descriptions and Specifications
Table 113. Takeda Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Takeda Recent Developments
Table 115. Hengrui Pharmaceuticals Corporation Information
Table 116. Hengrui Pharmaceuticals Description and Major Businesses
Table 117. Hengrui Pharmaceuticals Product Models, Descriptions and Specifications
Table 118. Hengrui Pharmaceuticals Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Hengrui Pharmaceuticals Recent Developments
Table 120. Brilliant Pharmaceutical Corporation Information
Table 121. Brilliant Pharmaceutical Description and Major Businesses
Table 122. Brilliant Pharmaceutical Product Models, Descriptions and Specifications
Table 123. Brilliant Pharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Brilliant Pharmaceutical Recent Developments
Table 125. Shenghuaxi Pharmaceutical Corporation Information
Table 126. Shenghuaxi Pharmaceutical Description and Major Businesses
Table 127. Shenghuaxi Pharmaceutical Product Models, Descriptions and Specifications
Table 128. Shenghuaxi Pharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Shenghuaxi Pharmaceutical Recent Developments
Table 130. Neptunus Bio-pharmaceutical Corporation Information
Table 131. Neptunus Bio-pharmaceutical Description and Major Businesses
Table 132. Neptunus Bio-pharmaceutical Product Models, Descriptions and Specifications
Table 133. Neptunus Bio-pharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Neptunus Bio-pharmaceutical Recent Developments
Table 135. YRPG Corporation Information
Table 136. YRPG Description and Major Businesses
Table 137. YRPG Product Models, Descriptions and Specifications
Table 138. YRPG Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. YRPG Recent Developments
Table 140. CTTQ Corporation Information
Table 141. CTTQ Description and Major Businesses
Table 142. CTTQ Product Models, Descriptions and Specifications
Table 143. CTTQ Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. CTTQ Recent Developments
Table 145. Consun Pharmaceutical Corporation Information
Table 146. Consun Pharmaceutical Description and Major Businesses
Table 147. Consun Pharmaceutical Product Models, Descriptions and Specifications
Table 148. Consun Pharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Consun Pharmaceutical Recent Developments
Table 150. Liebel-Flarsheim Company LLC Corporation Information
Table 151. Liebel-Flarsheim Company LLC Description and Major Businesses
Table 152. Liebel-Flarsheim Company LLC Product Models, Descriptions and Specifications
Table 153. Liebel-Flarsheim Company LLC Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Liebel-Flarsheim Company LLC Recent Developments
Table 155. BeiLu Pharma Corporation Information
Table 156. BeiLu Pharma Description and Major Businesses
Table 157. BeiLu Pharma Product Models, Descriptions and Specifications
Table 158. BeiLu Pharma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. BeiLu Pharma Recent Developments
Table 160. Cadiasun Pharma GmbH Corporation Information
Table 161. Cadiasun Pharma GmbH Description and Major Businesses
Table 162. Cadiasun Pharma GmbH Product Models, Descriptions and Specifications
Table 163. Cadiasun Pharma GmbH Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Cadiasun Pharma GmbH Recent Developments
Table 165. Key Raw Materials Distribution
Table 166. Raw Materials Key Suppliers
Table 167. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 168. Milestones in Production Technology Evolution
Table 169. Distributors List
Table 170. Market Trends and Market Evolution
Table 171. Market Drivers and Opportunities
Table 172. Market Challenges, Risks, and Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources


List of Figures
Figure 1. Iodinated X-Ray Contrast Media Product Picture
Figure 2. Global Iodinated X-Ray Contrast Media Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Ioversol Product Picture
Figure 4. Iobitrol Product Picture
Figure 5. Iohexol Product Picture
Figure 6. Iodixanol Product Picture
Figure 7. Others Product Picture
Figure 8. Global Iodinated X-Ray Contrast Media Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Iodinated X-Ray Contrast Media Report Years Considered
Figure 13. Global Iodinated X-Ray Contrast Media Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Iodinated X-Ray Contrast Media Revenue (2020-2031) & (US$ Million)
Figure 15. Global Iodinated X-Ray Contrast Media Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Iodinated X-Ray Contrast Media Revenue Market Share by Region (2020-2031)
Figure 17. Global Iodinated X-Ray Contrast Media Sales (2020-2031) & (Units)
Figure 18. Global Iodinated X-Ray Contrast Media Sales (CAGR) by Region (2020-2031) (Units)
Figure 19. Global Iodinated X-Ray Contrast Media Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Iodinated X-Ray Contrast Media Sales Volume Market Share in 2024
Figure 21. Global Iodinated X-Ray Contrast Media Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. Ioversol Revenue Market Share by Manufacturer in 2024
Figure 24. Iobitrol Revenue Market Share by Manufacturer in 2024
Figure 25. Iohexol Revenue Market Share by Manufacturer in 2024
Figure 26. Iodixanol Revenue Market Share by Manufacturer in 2024
Figure 27. Others Revenue Market Share by Manufacturer in 2024
Figure 28. Global Iodinated X-Ray Contrast Media Sales Market Share by Type (2020-2031)
Figure 29. Global Iodinated X-Ray Contrast Media Revenue Market Share by Type (2020-2031)
Figure 30. Global Iodinated X-Ray Contrast Media Sales Market Share by Application (2020-2031)
Figure 31. Global Iodinated X-Ray Contrast Media Revenue Market Share by Application (2020-2031)
Figure 32. North America Iodinated X-Ray Contrast Media Sales YoY (2020-2031) & (Units)
Figure 33. North America Iodinated X-Ray Contrast Media Revenue YoY (2020-2031) & (US$ Million)
Figure 34. North America Top 5 Manufacturers Iodinated X-Ray Contrast Media Sales Revenue (US$ Million) in 2024
Figure 35. North America Iodinated X-Ray Contrast Media Sales Volume (Units) by Type (2020- 2031)
Figure 36. North America Iodinated X-Ray Contrast Media Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 37. North America Iodinated X-Ray Contrast Media Sales Volume (Units) by Application (2020-2031)
Figure 38. North America Iodinated X-Ray Contrast Media Sales Revenue (US$ Million) by Application (2020-2031)
Figure 39. US Iodinated X-Ray Contrast Media Revenue (2020-2031) & (US$ Million)
Figure 40. Canada Iodinated X-Ray Contrast Media Revenue (2020-2031) & (US$ Million)
Figure 41. Mexico Iodinated X-Ray Contrast Media Revenue (2020-2031) & (US$ Million)
Figure 42. Europe Iodinated X-Ray Contrast Media Sales YoY (2020-2031) & (Units)
Figure 43. Europe Iodinated X-Ray Contrast Media Revenue YoY (2020-2031) & (US$ Million)
Figure 44. Europe Top 5 Manufacturers Iodinated X-Ray Contrast Media Sales Revenue (US$ Million) in 2024
Figure 45. Europe Iodinated X-Ray Contrast Media Sales Volume (Units) by Type (2020-2031)
Figure 46. Europe Iodinated X-Ray Contrast Media Sales Revenue (US$ Million) by Type (2020-2031)
Figure 47. Europe Iodinated X-Ray Contrast Media Sales Volume (Units) by Application (2020-2031)
Figure 48. Europe Iodinated X-Ray Contrast Media Sales Revenue (US$ Million) by Application (2020-2031)
Figure 49. Germany Iodinated X-Ray Contrast Media Revenue (2020-2031) & (US$ Million)
Figure 50. France Iodinated X-Ray Contrast Media Revenue (2020-2031) & (US$ Million)
Figure 51. U.K. Iodinated X-Ray Contrast Media Revenue (2020-2031) & (US$ Million)
Figure 52. Italy Iodinated X-Ray Contrast Media Revenue (2020-2031) & (US$ Million)
Figure 53. Russia Iodinated X-Ray Contrast Media Revenue (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Iodinated X-Ray Contrast Media Sales YoY (2020-2031) & (Units)
Figure 55. Asia-Pacific Iodinated X-Ray Contrast Media Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Asia-Pacific Top 8 Manufacturers Iodinated X-Ray Contrast Media Sales Revenue (US$ Million) in 2024
Figure 57. Asia-Pacific Iodinated X-Ray Contrast Media Sales Volume (Units) by Type (2020- 2031)
Figure 58. Asia-Pacific Iodinated X-Ray Contrast Media Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 59. Asia-Pacific Iodinated X-Ray Contrast Media Sales Volume (Units) by Application (2020-2031)
Figure 60. Asia-Pacific Iodinated X-Ray Contrast Media Sales Revenue (US$ Million) by Application (2020-2031)
Figure 61. Indonesia Iodinated X-Ray Contrast Media Revenue (2020-2031) & (US$ Million)
Figure 62. Japan Iodinated X-Ray Contrast Media Revenue (2020-2031) & (US$ Million)
Figure 63. South Korea Iodinated X-Ray Contrast Media Revenue (2020-2031) & (US$ Million)
Figure 64. China Taiwan Iodinated X-Ray Contrast Media Revenue (2020-2031) & (US$ Million)
Figure 65. India Iodinated X-Ray Contrast Media Revenue (2020-2031) & (US$ Million)
Figure 66. Central and South America Iodinated X-Ray Contrast Media Sales YoY (2020-2031) & (Units)
Figure 67. Central and South America Iodinated X-Ray Contrast Media Revenue YoY (2020-2031) & (US$ Million)
Figure 68. Central and South America Top 5 Manufacturers Iodinated X-Ray Contrast Media Sales Revenue (US$ Million) in 2024
Figure 69. Central and South America Iodinated X-Ray Contrast Media Sales Volume (Units) by Type (2021-2031)
Figure 70. Central and South America Iodinated X-Ray Contrast Media Sales Revenue (US$ Million) by Type (2020-2031)
Figure 71. Central and South America Iodinated X-Ray Contrast Media Sales Volume (Units) by Application (2020-2031)
Figure 72. Central and South America Iodinated X-Ray Contrast Media Sales Revenue (US$ Million) by Application (2020-2031)
Figure 73. Brazil Iodinated X-Ray Contrast Media Revenue (2020-2025) & (US$ Million)
Figure 74. Argentina Iodinated X-Ray Contrast Media Revenue (2020-2025) & (US$ Million)
Figure 75. Middle East, and Africa Iodinated X-Ray Contrast Media Sales YoY (2020-2031) & (Units)
Figure 76. Middle East and Africa Iodinated X-Ray Contrast Media Revenue YoY (2020-2031) & (US$ Million)
Figure 77. Middle East and Africa Top 5 Manufacturers Iodinated X-Ray Contrast Media Sales Revenue (US$ Million) in 2024
Figure 78. Middle East and Africa Iodinated X-Ray Contrast Media Sales Volume (Units) by Type (2021-2031)
Figure 79. South America Iodinated X-Ray Contrast Media Sales Revenue (US$ Million) by Type (2020-2031)
Figure 80. Middle East and Africa Iodinated X-Ray Contrast Media Sales Volume (Units) by Application (2020-2031)
Figure 81. Middle East and Africa Iodinated X-Ray Contrast Media Sales Revenue (US$ Million) by Application (2020-2031)
Figure 82. GCC Countries Iodinated X-Ray Contrast Media Revenue (2020-2025) & (US$ Million)
Figure 83. Turkey Iodinated X-Ray Contrast Media Revenue (2020-2025) & (US$ Million)
Figure 84. Egypt Iodinated X-Ray Contrast Media Revenue (2020-2025) & (US$ Million)
Figure 85. South Africa Iodinated X-Ray Contrast Media Revenue (2020-2025) & (US$ Million)
Figure 86. Iodinated X-Ray Contrast Media Industry Chain Mapping
Figure 87. Regional Iodinated X-Ray Contrast Media Manufacturing Base Distribution (%)
Figure 88. Global Iodinated X-Ray Contrast Media Production Market Share by Region (2020-2031)
Figure 89. Iodinated X-Ray Contrast Media Production Process
Figure 90. Regional Iodinated X-Ray Contrast Media Production Cost Structure
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit